References
- Eriksson A W, Foltmann B, Frants R R, Gedde-Dahl T, Samloff I M, Taggart R T. Nomenclature committee report. Pepsinogens in man. Clinical and genetic advances, J M Kreuning, I M Samloff, J I Rotter, A W Eriksson. The Pharmaceutical Press, New York Alan R. Liss 1985; 41–2
- Samloff I M, Varis K I, Ihamaki T, Siurala M, Rotter J I. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982; 83: 204–9
- Samloff I M, Liebman W M. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973; 65: 36–42
- Samloff I M. Pepsinogens I and II. Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982; 82: 26–33
- Axelsson C K, Nielsen M D, Kappelgaard A M. Solid-phase double-antibody radioimmunoassay of pepsinogen I in serum. Clin Chim Acta 1982; 121: 309–19
- Samloff I M, Liebman W M. Radioimmunoassay of group I pepsinogens in serum. Gastroenterology 1974; 66: 494–502
- Vianello F, Plebani M, Piccoli A. Role of serum pepsinogen in detecting ulcer disease. Clin Chim Acta 1988; 172: 335–40
- Rotter J I, Sones J Q, Samloff I M. Duodenal ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med 1979; 300: 63–6
- Hengels K J, Halfkann M, Zeidler H, Strohmeyer G. Erkennung und Verlaufskontrolle spontaner und antiphlogistika-induzierter gastroduodenaler Läsionen durch Serumpepsinogenbestimmung [abstract]. Klin Wochenschr 1988; 66(Suppl 13)202
- Kullich W, Pöllmann G, Zmerekar C, Klein G. Stellenwert der Bestimmung von Pepsinogen I im serum als Screeningmethode zur Früherkennung gastroduodenal läsionen und als Verlaufskontrolle unter der Therapie mit nicht-steroidalen Antirheumatika. Z Rheumatol 1991; 59: 39–45
- Aabakken L, Larsen S, Osnes M. Visual analogue scales for endoscopic evaluation of NSAID-induced mucosal damage in the stomach and duodenum. Scand J Gastroenterol 1990; 25: 443–8
- Szecsi P B, Halgreen H, Poulsen S S. Demonstration of pepsinogen C in human pancreatic islets. Gut 1987; 28: 1208–14
- Markwell M AK. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labelling of antiserum. Anal Biochem 1982; 125: 427–32
- Kullich W, Klein G, Pöllmann G. Influence of lornoxicam on serum pepsinogen levels. Postgrad Med J 1990; 66: S46–8
- Roth S H. NSAID gastropathy: we started it-can we stop it?. Arch Intern Med 1986; 146: 1075–6